LL-37
Research PeptideAlso known as: Cathelicidin, hCAP18
What is LL-37?
LL-37 is a human antimicrobial peptide with broad-spectrum activity against bacteria, viruses, and fungi, plus immunomodulatory effects.
How It Works
LL-37 disrupts microbial membranes, modulates immune responses, promotes wound healing, and has anti-biofilm properties.
What Research Shows
Key Findings:
- Broad antimicrobial activity
- Promotes wound healing
- May help with chronic infections
Limited Human Research
Most research on LL-37 has been conducted in animal models. Human clinical trials are limited or absent. Results may not translate directly to humans.
Dosing Protocol
These are general guidelines based on research literature and community protocols. Individual dosing should be determined by a qualified healthcare provider.
Safety & Risks
Reported Side Effects:
Contraindications:
- Autoimmune conditions
- Pregnancy
Important: This information is for research purposes only. Always consult with a qualified healthcare provider before using any peptide. Never use peptides without proper medical supervision.
Sourcing & Quality
Quality varies significantly between peptide sources. When sourcing LL-37, consider:
- Third-party testing (HPLC, Mass Spectrometry)
- Certificate of Analysis (CoA) availability
- Purity levels (>98% recommended)
- Beware of LPS (endotoxin) contamination
CalcPep does not sell peptides or recommend specific vendors. Always verify product quality through independent testing.
Aggregated from CalcPep users who have opted in to share anonymous data.
View Full DataTrack Your Protocol
Use CalcPep to calculate doses, log injections, and track your progress.
Get CalcPep